OCTIMET Oncology SA
OCTIMET Oncology reported total assets of 252,753 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jul 2026).
The score of OCTIMET Oncology shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -59 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
OCTIMET Oncology's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −95,727 € | ||||
| Equity | 243,628 € | ||||
| Cash | 29,192 € | ||||
| EBITDA | −16,989 € | ||||
| Total assets | 252,753 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 27 Jun 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 30 May 2022
OCTIMET Oncology's financial analysis
- Solvency96.4%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of OCTIMET Oncology
OCTIMET Oncology's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0651.853.757
- VAT number
- BE0651853757
- Peppol
- Registered · 0208:0651853757 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 12 Apr 2016
- Registered office
- 2440 Geel
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
OCTIMET Oncology (SA) has been based in Geel since 2016, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 95,727 € and equity of 243,628 €; its revenue is not published. Its solvency stands at 96.4%, above the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to OCTIMET Oncology
Companies in the same business, of comparable size and area, outside its group.
- Groovy.Bio Manufacture of pharmaceutical preparations Evergem · balance sheet 744,069 €
- CellCarta Biosciences Research and experimental development on natural sciences and engineering Charleroi · balance sheet €22.4m
- Alnylam Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet €1.20m
- ERC Belgium Research and experimental development on natural sciences and engineering Gembloux · balance sheet €11.6m
- AstriVax Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet €12.5m
- ConvEyXo Research and experimental development on natural sciences and engineering Charleroi · balance sheet €10.3m
- OSIVAX Belgique Research and experimental development on natural sciences and engineering Liège · balance sheet €17.0m
- Aboleris Holdco Research and experimental development on natural sciences and engineering Charleroi · balance sheet €14.8m
Frequently asked questions about OCTIMET Oncology
What is the revenue of OCTIMET Oncology?
OCTIMET Oncology files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of OCTIMET Oncology?
In Belgium, the VAT number is the company number prefixed with BE: BE0651853757 for OCTIMET Oncology, if the company is VAT-registered. Its company number (CBE) is 0651.853.757.
Where is the registered office of OCTIMET Oncology?
According to the CBE register, the registered office of OCTIMET Oncology is in 2440 Geel.
What is the equity of OCTIMET Oncology?
At the close of the 2025 financial year, the equity of OCTIMET Oncology amounts to 243,628 €, a solvency of 96.4% of total assets.
Who manages OCTIMET Oncology?
The register lists 2 active mandates at OCTIMET Oncology. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of OCTIMET Oncology
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →